Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam I Raad

Showing results (161-170 of 165) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 165 results.
Elife|February 7, 2023
Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time periodHiba Dagher, Anne-Marie Chaftari, Ishwaria M Subbiah, et al.
Oncology|July 3, 2009
Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experienceJames D Cox, Sergio A Giralt, Mary L Veazie, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2024
Artificial Intelligence Assessment of Chest Radiographs for COVID-19Koji Sasaki, Guillermo Garcia-Manero, Masayuki Nigo, et al.
Lancet (London, England)|December 20, 2015
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trialJohan A Maertens, Issam I Raad, Kieren A Marr, et al.
Elife|January 30, 2023
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorshipIssam I Raad, Ray Hachem, Nigo Masayuki, et al.
Pageof 17

Showing results (161-170 of 165) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 165 results.
Elife|February 7, 2023
Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time periodHiba Dagher, Anne-Marie Chaftari, Ishwaria M Subbiah, et al.
Oncology|July 3, 2009
Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experienceJames D Cox, Sergio A Giralt, Mary L Veazie, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 22, 2024
Artificial Intelligence Assessment of Chest Radiographs for COVID-19Koji Sasaki, Guillermo Garcia-Manero, Masayuki Nigo, et al.
Lancet (London, England)|December 20, 2015
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trialJohan A Maertens, Issam I Raad, Kieren A Marr, et al.
Elife|January 30, 2023
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorshipIssam I Raad, Ray Hachem, Nigo Masayuki, et al.
Pageof 17